Trial Profile
Impact of Combined Ezetimibe and Atorvastatin Therapy on Coronary Thin-cap Fibroatheroma As Assessed by Optical Coherence Tomography
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin
- Indications Coronary artery disease
- Focus Therapeutic Use
- 30 Oct 2015 New trial record